Kewaunee Scientific Corp

Kewaunee Scientific Corp(KEQU)の株式分析

$32.570

+0.384 (+1.18%)終値時点

Loading chart…
高値
32.925
始値
32.925
出来高加重平均価格
32.81
出来高
1.33K
時価総額
122.74M
安値
32.925
売買代金
43.76K
EV/EBITDA(TTM)
0.00

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

kewaunee.com

AI分析 of Kewaunee Scientific Corp (KEQU)

中立

Kewaunee Scientific Corp is not a strong buy at the moment due to declining profitability and revenue, despite a low forward P/E of 7.716, indicating potential value. The current RSI of 38.604 suggests the stock is nearing oversold territory, but the recent 1-year change of -18.36% raises concerns about its stability. The main risk is the decline in Q4 profit to $3.39 million, down from $4.85 million last year, which may affect investor confidence moving forward.

アナリスト評価(1)

買い
1 買い
0 中立
0 売り
現在: 32.57
安値
—
平均
—
高値
—

バリュエーション指標

Kewaunee Scientific Corp(KEQU)の現在の予想PERは7.72で、5年平均は12.75です。

予想PER

適正
5年平均 P/E
12.75
現在のP/E
7.72
割高
19.62
割安
5.88

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
9.42
現在のEV/EBITDA
0.00
割高
13.69
割安
5.14

予想PSR

割安
5年平均 P/S
0.54
現在のP/S
0.00
割高
0.82
割安
0.26

Alphio AI による KEQU の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%KEQU

$74.07

シナリオ価格

基

基本

基本 · 50%KEQU

$63.47

シナリオ価格

弱

弱気

弱気 · 25%KEQU

$57.33

シナリオ価格

イベントタイムライン

2026-09-09 (ET)

19:30:00

US Indices Down for Third Day as Oil Prices Rise

16:30:00

Kewaunee Reports Q1 Revenue of $66.32M

2026-06-23 (ET)

17:30:00

Kewaunee Reports Q4 Revenue of $71.4M

2026-03-11 (ET)

16:10:00

Kewaunee Reports Q3 Revenue of $69.4M, Successfully Acquires Nu Aire

2025-09-10 (ET)

16:11:48

Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year

ニュース

KEQU のよくある質問 — Alphio AI が回答

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. It operates in the Industrials sector (LABORATORY APPARATUS & FURNITURE industry).

Kewaunee Scientific Corp is not a strong buy at the moment due to declining profitability and revenue, despite a low forward P/E of 7.716, indicating potential value. The current RSI of 38.604 suggests the stock is nearing oversold territory, but the recent 1-year change of -18.36% raises concerns about its stability. The main risk is the decline in Q4 profit to $3.39 million, down from $4.85 million last year, which may affect investor confidence moving forward.

1 analysts cover KEQU: 1 rate it Buy, 0 Hold and 0 Sell.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める